Liberia: Prevail Begins Clinical Research On Lassa Fever Study Vaccine

[FrontPageAfrica] Monrovia -- The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States research partnership, has launched a Phase I clinical study to evaluate a candidate Lassa fever vaccine in adults of good health in Liberia.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news